Protective Immune Responses Generated in a Murine Model Following Immunization with Recombinant Schistosoma japonicum Insulin Receptor

There is a pressing need to develop vaccines for schistosomiasis given the current heavy dependency on praziquantel as the only available drug for treatment. We previously showed the ligand domain of the Schistosoma japonicum insulin receptor 1 and 2 (rSjLD1 and 2) fusion proteins conferred solid protection in mice against challenge infection with S. japonicum. To improve vaccine efficacy, we compared the immunogenicity and protective efficacy of rSjLD1 on its own and in combination with S. japonicum triose-phosphate isomerase (SjTPI), formulated with either of two adjuvants (QuilA and montanide ISA 720VG) in murine vaccine trials against S. japonicum challenge. The level of protection was higher in mice vaccinated only with rSjLD1 formulated with either adjuvant; rSjTPI or the rSjTPI-rSjLD1 combination resulted in a lower level of protection. Mirroring our previous results, there were significant reductions in the number of female worms (30–44%), faecal eggs (61–68%), liver eggs (44–56%), intestinal eggs (46–48%) and mature intestinal eggs (58–63%) in the rSjLD1-vaccinated mice compared with the adjuvant only groups. At 6-weeks post-cercarial challenge, a significantly increased production of interferon gamma (IFNγ) in rSjLD1-stimulated splenic CD4+ T cells was observed in the rSjLD1-vaccinated mice suggesting a Th1-type response is associated with the generated level of protective efficacy.

[1]  Yuesheng Li,et al.  Schistosome Vaccines for Domestic Animals , 2018, Tropical medicine and infectious disease.

[2]  D. McManus,et al.  A Parallel Comparison of Antigen Candidates for Development of an Optimized Serological Diagnosis of Schistosomiasis Japonica in the Philippines , 2017, EBioMedicine.

[3]  J. Dai,et al.  Evaluation of protective efficacy induced by different heterologous prime-boost strategies encoding triosephosphate isomerase against Schistosoma japonicum in mice , 2017, Parasites & Vectors.

[4]  D. Richard,et al.  Sex Hormone Binding Globulin Modifies Testosterone Action and Metabolism in Prostate Cancer Cells , 2016, International journal of endocrinology.

[5]  J. Dalton,et al.  A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis , 2016, BMC Infectious Diseases.

[6]  R. Wilson,et al.  Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data? , 2016, Parasites & Vectors.

[7]  Yingying Chen,et al.  SjTat-TPI facilitates adaptive T-cell responses and reduces hepatic pathology during Schistosoma japonicum infection in BALB/c mice , 2015, Parasites & Vectors.

[8]  D. McManus,et al.  Suppression of the Insulin Receptors in Adult Schistosoma japonicum Impacts on Parasite Growth and Development: Further Evidence of Vaccine Potential , 2015, PLoS neglected tropical diseases.

[9]  J. Dai,et al.  Enhancement of Protective Efficacy through Adenoviral Vectored Vaccine Priming and Protein Boosting Strategy Encoding Triosephosphate Isomerase (SjTPI) against Schistosoma japonicum in Mice , 2015, PloS one.

[10]  J. Dalton,et al.  Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant. , 2015, Vaccine.

[11]  H. Tallima,et al.  Why the radiation-attenuated cercarial immunization studies failed to guide the road for an effective schistosomiasis vaccine: A review , 2014, Journal of advanced research.

[12]  A. Da'dara,et al.  Schistosome Syntenin Partially Protects Vaccinated Mice against Schistosoma mansoni Infection , 2014, PLoS neglected tropical diseases.

[13]  A. Loukas,et al.  A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP‐2 and Sm29 was able to induce protection against infection in mice , 2014, Parasite immunology.

[14]  A. Wolstenholme,et al.  FGT-1 is the major glucose transporter in C. elegans and is central to aging pathways , 2013, The Biochemical journal.

[15]  D. McManus,et al.  High Prevalence of Schistosoma japonicum Infection in Carabao from Samar Province, the Philippines: Implications for Transmission and Control , 2012, PLoS neglected tropical diseases.

[16]  Yuesheng Li,et al.  The insulin receptor is a transmission blocking veterinary vaccine target for zoonotic Schistosoma japonicum. , 2012, International journal for parasitology.

[17]  Jianmei Yang,et al.  Comparison of worm development and host immune responses in natural hosts of schistosoma japonicum, yellow cattle and water buffalo , 2012, BMC Veterinary Research.

[18]  A. Siddiqui,et al.  Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models. , 2011, Vaccine.

[19]  Azza Hassan,et al.  Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies , 2010, Parasitology Research.

[20]  D. McManus,et al.  Cloning and Characterisation of Schistosoma japonicum Insulin Receptors , 2010, PloS one.

[21]  R. Corrêa-Oliveira,et al.  Schistosoma mansoni Stomatin Like Protein-2 Is Located in the Tegument and Induces Partial Protection against Challenge Infection , 2010, PLoS neglected tropical diseases.

[22]  P. Brindley,et al.  Developmental gene expression profiles of the human pathogen Schistosoma japonicum , 2009, BMC Genomics.

[23]  A. Thomas,et al.  Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine? , 2008, PLoS neglected tropical diseases.

[24]  E. Reis,et al.  Schistosoma mansoni Triose Phosphate Isomerase Peptide MAP4 is Able to Trigger Naïve Donor Immune Response Towards a Type‐1 Cytokine Profile , 2008, Scandinavian journal of immunology.

[25]  Gail M. Williams,et al.  DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. , 2008, Vaccine.

[26]  M. Saber,et al.  Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine. , 2008, Acta biochimica et biophysica Sinica.

[27]  Alex Loukas,et al.  Current Status of Vaccines for Schistosomiasis , 2008, Clinical Microbiology Reviews.

[28]  Yuesheng Li,et al.  [Protective effects of co-immunization with SjCTPI-Hsp70 and interleukin-12 DNA vaccines against Schistosoma japonicum challenge infection in water buffalo]. , 2006, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases.

[29]  A. Loukas,et al.  Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis , 2006, Nature Medicine.

[30]  D. Harn,et al.  Schistosoma japonicum triose-phosphate isomerase plasmid DNA vaccine protects pigs against challenge infection , 2005, Parasitology.

[31]  P. Hamblin,et al.  Immunity induced by the radiation‐attenuated schistosome vaccine , 2005, Parasite immunology.

[32]  C. Czerkinsky,et al.  Current status and future prospects for a vaccine against schistosomiasis , 2004, Expert review of vaccines.

[33]  G. Coles,et al.  Schistosomiasis control: keep taking the tablets. , 2004, Trends in parasitology.

[34]  Edward J. Pearce,et al.  The immunobiology of schistosomiasis , 2002, Nature Reviews Immunology.

[35]  D. Harn,et al.  The protective immunity produced in infected C57BL/6 mice of a DNA vaccine encoding Schistosoma japonicum chinese strain triose-phosphate isomerase , 2002 .

[36]  Gail M. Williams,et al.  Current concepts - Schistosomiasis , 2002 .

[37]  T. Thomas,et al.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension , 2002, Gut.

[38]  P. Brindley,et al.  Bacterial expression and characterization of functional recombinant triosephosphate isomerase from Schistosoma japonicum. , 1999, Protein expression and purification.

[39]  T. Wynn,et al.  IMMUNOPATHOLOGY OF SCHISTOSOMIASIS , 1987, The Lancet.

[40]  E. Bueding.  CARBOHYDRATE METABOLISM OF SCHISTOSOMA MANSONI , 1950, The Journal of general physiology.

[41]  N. Araújo,et al.  Evaluation of the protective immune response induced in mice by immunization with Schistosoma mansoni schistosomula tegument (Smteg) in association with CpG-ODN. , 2013, Microbes and infection.

[42]  Chuan-Xin Yu,et al.  The protective immunity produced in infected C57BL/6 mice of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase. , 2002, The Southeast Asian journal of tropical medicine and public health.